Clinical Trial Update: EMPATHY NSCLC: European Registry for Plasma-Based Molecular Profiling in Advanced NSCLC Patients

View source ↗

Summary

This document describes the EMPATHY NSCLC study, a European registry for plasma-based molecular profiling in patients with advanced non-small cell lung cancer, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Hedera Dx SA | Conditions: NSCLC (Advanced Non-small Cell Lung Cancer) | Status: RECRUITING